Recent studies support the use of pharmacotherapy in the treatment of dysthymic disorder. This article reviews the relationship of the definition of dysthymic disorder to clinical treatment studies and discusses the treatment of dysthymic disorder with pharmacotherapy (with special emphasis on the u
Dysthymic disorder: Treatment with mirtazapine
โ Scribed by David L. Dunner; Helen E. Hendrickson; Carolyn Bea; Chris B. Budech; Elsa O'Connor
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 48 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1091-4269
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Alone or as part of a multidrug immunosuppressive regimen, cyclosporine A (CsA) has been reported in isolated case studies as a cause of muscle disorders. We reviewed the current knowledge on muscle toxicity of CsA and discussed the possible role of mitochondrial dysfunction in the genesis of CsA-as
## Background: The over-representation of female prisoners with borderline personality disorder (bpd) is an area of concern for hm prison service. pilot programmes of dialectical behaviour therapy (dbt) were undertaken for the first time in three british prisons for women diagnosed with bpd. standa